Key Highlights
- In late October 2026 the US Nuclear Regulatory Commission (NRC) issued its final environmental impact statement for the proposed Paducah Laser Enrichment Facility in Kentucky, planned by.
- The final environmental impact statement recommends issuing a construction and operation licence.
- For Silex Systems, an S&P/ASX 200 constituent that owns 51 per cent of GLE, the document removes one of the two main remaining regulatory hurdles.
- The Paducah plant is designed to re-enrich depleted uranium tails from the former Paducah gaseous diffusion plant, and to enrich natural uranium.
Silex Systems (ASX:SLX) is a Sydney-based technology company that developed the SILEX laser isotope separation process.
A regulatory step, not yet a licence
In late October 2026 the US Nuclear Regulatory Commission (NRC) issued its final environmental impact statement for the proposed Paducah Laser Enrichment Facility in Kentucky, planned by Global Laser Enrichment (GLE). The final environmental impact statement recommends issuing a construction and operation licence.
For Silex Systems, an S&P/ASX 200 constituent that owns 51 per cent of GLE, the document removes one of the two main remaining regulatory hurdles. It does not, however, amount to a licence. A final safety evaluation report is still required, and Silex says it expects the licence to be finalised in early 2027.
What Silex does
Silex is a Sydney-based technology company that developed the SILEX laser isotope separation process. Its main application is uranium enrichment, which GLE is commercialising in the United States as the exclusive licensee. Canadian uranium producer Cameco holds the remaining 49 per cent of GLE and, according to the annual report, has an option to acquire a further 26 per cent interest, exercisable until April 2028.
The company is also applying the technology to silicon, aiming to produce highly enriched silicon-28 for silicon-based quantum computers.
Recent developments
The Paducah plant is designed to re-enrich depleted uranium tails from the former Paducah gaseous diffusion plant, and to enrich natural uranium. The American Nuclear Society reports planned capacity of up to six million separative work units a year. The licence would also cover LEU+ up to 8 per cent uranium-235.
In September 2026 GLE agreed an exclusive offtake arrangement under which Cameco would buy all future production from the plant. The offtake arrangement specifies pricing linked to Cameco's long-term contract portfolio, net of selling costs, and that Silex sees the deal as supporting a future final Investment decision.
Earlier in 2026 GLE was selected for a US$28.5 million Department of Energy award and received preliminary approval for state and county incentives of up to US$98.9 million. Shareholders carried all resolutions at the 16 October annual general meeting.
Financial position
Silex's 2026 annual report, covering the year to 30 June 2026, showed Revenue from continuing operations of $21.6 million, up from $12.2 million, helped by $7.6 million of milestone revenue linked to GLE reaching Technology Readiness Level 6 at its Wilmington, North Carolina test loop. The net loss narrowed to $38.6 million from $42.6 million, although Silex's share of GLE losses rose to $45.5 million.
Cash and term deposits stood at about $180.7 million at 30 June 2026, with no corporate debt, reflecting the August 2025 Capital raising. No Dividend was paid or declared. Silex remains a pre-commercial Business that is funding development.
Risks and uncertainties
The licence is not yet granted, and NRC timing could shift. Commercial operation, targeted for 2030, depends on a feasibility study and a final investment decision, and a first-of-a-kind laser enrichment plant carries technical, cost and schedule risk. The TRL-7 maturation stage is still to be completed.
The Annual Report also flags exposure to nuclear fuel prices, better-funded competitors, US foreign ownership requirements, reliance on government agreements, geopolitical risks and possible disagreements with Cameco. The quantum silicon market remains small today.
Milestones to watch
The near-term item is the NRC's final safety evaluation report, which is expected by the end of 2026, followed by the licensing decision Silex expects in early 2027. Progress on the feasibility study, the TRL-7 program and any Cameco option exercise also matter.
On the silicon side, Silex completed its Quantum Silicon production plant in Sydney in June 2026 and expects sample production to begin in the first quarter of calendar 2027. The half-year result, typically released around February, should provide an update on cash and spending.






Please wait processing your request...